MET and neoplasm: After chemoimmunotherapy, the patient exhibited a MET amplified tumor (mean MET copies 11.2 and MET/CEP7 ratio of 3.6) with MET amplification in approximately 93% of cells and concordant strong, diffuse membranous phospho-MET IHC staining (Fig. 4B, right).